Sol-gel technologies appoints michael glezin vice president, business development

Ness ziona, israel, oct. 03, 2022 (globe newswire) -- sol-gel technologies, ltd. (nasdaq: slgl), a dermatology company focused on identifying, developing, commercializing or partnering branded and generic topical drug products for the treatment of skin diseases, announced today the appointment of michael glezin to the position of vice president, business development. in this position, mr. glezin will be responsible for identifying new in-licensing business opportunities as well as potential commercial partners for the company's approved products in ex-us territories.
SLGL Ratings Summary
SLGL Quant Ranking